New to ALVARA? Get 20% off your first order — use code HIVE20 at checkout.
Boston BioLife 2026 was a landmark event for Alvara — marking the debut of our second production run, the official launch of Alvara Labs, and the addition of Dr. Glen Rein as Chief Scientist. The event opened a direct channel to 120,000+ vetted healthcare practitioners through a new webinar partnership.
Held at the Scottsdale Marriott from February 27 through March 1, 2026, Boston BioLife is one of the premier integrative medicine conferences in North America. Alvara's presence at the event positioned MycoNectar directly in front of the practitioners, researchers, and healthcare innovators who are shaping the future of functional wellness.
Boston BioLife marked the official debut of Alvara's second production run of MycoNectar — a significant milestone in scaling the brand's capacity while maintaining small-batch integrity.
A landmark moment for Alvara: Dr. Glen Rein — a world-renowned researcher in bioelectromagnetics, sound healing, and the science of consciousness — officially joined as Chief Scientist.
The official launch of Alvara Labs — the research and development arm of the company — was announced at Boston BioLife, signaling Alvara's commitment to clinical validation and innovation.
A new webinar partnership was established reaching 120,000+ vetted healthcare practitioners — giving MycoNectar direct access to the professional wellness community at scale.